| Danielle Stevens, MD | |
|
2801 Debarr Rd, Anchorage, AK 99508-2997 | |
| (907) 276-1131 | |
| Not Available |
| Full Name | Danielle Stevens |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 2801 Debarr Rd, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205280013 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 172681 (Alaska) | Secondary |
| 207P00000X | Emergency Medicine | R8669 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alaska Regional Hospital | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Denali Emergency Medicine Assoc Pc | 0042102287 | 20 |
News Archive
In a technical tour de force, structural biologists funded by the National Institutes of Health have determined the three-dimensional structure of a molecule involved in HIV infection and in many forms of cancer. The high-resolution structure sheds light on how the molecule functions and could point to ways to control its activity, potentially locking out HIV and stalling cancer's spread.
COVID-19, the coronavirus disease of 2019, is one of the worst pandemics in human history. It emerged in December 2019 and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nearly 164 million SARS-CoV-2 infections and 3.4 million deaths have been reported globally since the beginning of the pandemic, which is still raging in many countries.
Rush University Medical Center in Chicago has been named a finalist for the American Hospital Association's Equity of Care Award for its efforts to reduce health care disparities and promote diversity within the organization's leadership and staff.
The amount of added sugar in the American diet has increased dramatically over the last 50 years. Much of that increase comes from higher intake of sugar-sweetened beverages, which constitute approximately one-third of the total added sugar consumption in the American diet.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.
› Verified 7 days ago
| Entity Name | Denali Emergency Medicine Assoc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669406831 PECOS PAC ID: 0042102287 Enrollment ID: O20040325000219 |
News Archive
In a technical tour de force, structural biologists funded by the National Institutes of Health have determined the three-dimensional structure of a molecule involved in HIV infection and in many forms of cancer. The high-resolution structure sheds light on how the molecule functions and could point to ways to control its activity, potentially locking out HIV and stalling cancer's spread.
COVID-19, the coronavirus disease of 2019, is one of the worst pandemics in human history. It emerged in December 2019 and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nearly 164 million SARS-CoV-2 infections and 3.4 million deaths have been reported globally since the beginning of the pandemic, which is still raging in many countries.
Rush University Medical Center in Chicago has been named a finalist for the American Hospital Association's Equity of Care Award for its efforts to reduce health care disparities and promote diversity within the organization's leadership and staff.
The amount of added sugar in the American diet has increased dramatically over the last 50 years. Much of that increase comes from higher intake of sugar-sweetened beverages, which constitute approximately one-third of the total added sugar consumption in the American diet.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Stevens, MD 7350 Luke Ave Unit A, Jber, AK 99506-1205 Ph: (630) 632-2150 | Danielle Stevens, MD 2801 Debarr Rd, Anchorage, AK 99508-2997 Ph: (907) 276-1131 |
News Archive
In a technical tour de force, structural biologists funded by the National Institutes of Health have determined the three-dimensional structure of a molecule involved in HIV infection and in many forms of cancer. The high-resolution structure sheds light on how the molecule functions and could point to ways to control its activity, potentially locking out HIV and stalling cancer's spread.
COVID-19, the coronavirus disease of 2019, is one of the worst pandemics in human history. It emerged in December 2019 and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Nearly 164 million SARS-CoV-2 infections and 3.4 million deaths have been reported globally since the beginning of the pandemic, which is still raging in many countries.
Rush University Medical Center in Chicago has been named a finalist for the American Hospital Association's Equity of Care Award for its efforts to reduce health care disparities and promote diversity within the organization's leadership and staff.
The amount of added sugar in the American diet has increased dramatically over the last 50 years. Much of that increase comes from higher intake of sugar-sweetened beverages, which constitute approximately one-third of the total added sugar consumption in the American diet.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.
› Verified 7 days ago
John E Hall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-261-3111 Fax: 907-565-8066 | |
Sandra Lee Gailey, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1729 Fax: 907-729-1759 | |
Dr. Richard Wood, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 673 Mdg / Jb Elmendorf-richardson Usaf, 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-5556 | |
William D Longhurst, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-553-2662 | |
Dr. Leigh Martinez Wright, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Alaska Native Medical Center, Anchorage, AK 99508 Phone: 907-729-1729 | |
Dr. Frank H Moore, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-261-3111 Fax: 907-565-8066 | |
Tanya M Leinicke, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-565-8005 Fax: 907-565-8066 |